PixarBio (PixarBio) Accounts Payable & Accrued Expense : $0.01 Mil (As of Sep. 2016)

View and export this data going back to 2016. Start your Free Trial

What is PixarBio Accounts Payable & Accrued Expense?

PixarBio's quarterly accounts payable & accrued expense increased from Mar. 2016 ($0.13 Mil) to Jun. 2016 ($0.18 Mil) but then declined from Jun. 2016 ($0.18 Mil) to Sep. 2016 ($0.01 Mil).

PixarBio's annual accounts payable & accrued expense increased from . 20 ($0.00 Mil) to Dec. 2014 ($0.03 Mil) and increased from Dec. 2014 ($0.03 Mil) to Dec. 2015 ($0.09 Mil).

PixarBio Accounts Payable & Accrued Expense Historical Data

The historical data trend for PixarBio's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Accounts Payable & Accrued Expense Chart

PixarBio Annual Data

Trend

Dec14

Dec15

Accounts Payable & Accrued Expense

0.03

0.09

PixarBio Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial					0.09	0.09	0.13	0.18	0.01

PixarBio Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

PixarBio (PixarBio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155

Website

https://www.pixarbio.com

PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.